These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16395400)
1. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. Liotta LA; Petricoin EF J Clin Invest; 2006 Jan; 116(1):26-30. PubMed ID: 16395400 [TBL] [Abstract][Full Text] [Related]
2. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in mass spectrometry-based peptidome analysis. Hu L; Ye M; Zou H Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive peptidome analysis of mouse livers by size exclusion chromatography prefractionation and nanoLC-MS/MS identification. Hu L; Li X; Jiang X; Zhou H; Jiang X; Kong L; Ye M; Zou H J Proteome Res; 2007 Feb; 6(2):801-8. PubMed ID: 17269736 [TBL] [Abstract][Full Text] [Related]
5. The amplified peptidome: the new treasure chest of candidate biomarkers. Geho DH; Liotta LA; Petricoin EF; Zhao W; Araujo RP Curr Opin Chem Biol; 2006 Feb; 10(1):50-5. PubMed ID: 16418009 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis. Hashiguchi T; Tanaka K; Lee LJ; Sasaki K; Natsugoe S; Kawahara K; Arimura K; Maruyama I Med Hypotheses; 2009 Nov; 73(5):760-3. PubMed ID: 19477605 [TBL] [Abstract][Full Text] [Related]
7. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522 [TBL] [Abstract][Full Text] [Related]
8. Differential exoprotease activities confer tumor-specific serum peptidome patterns. Villanueva J; Shaffer DR; Philip J; Chaparro CA; Erdjument-Bromage H; Olshen AB; Fleisher M; Lilja H; Brogi E; Boyd J; Sanchez-Carbayo M; Holland EC; Cordon-Cardo C; Scher HI; Tempst P J Clin Invest; 2006 Jan; 116(1):271-84. PubMed ID: 16395409 [TBL] [Abstract][Full Text] [Related]
10. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool. Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224 [TBL] [Abstract][Full Text] [Related]
12. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry. Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144 [TBL] [Abstract][Full Text] [Related]
13. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Sarvaiya HA; Yoon JH; Lazar IM Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208 [TBL] [Abstract][Full Text] [Related]
14. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612 [TBL] [Abstract][Full Text] [Related]
15. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472 [TBL] [Abstract][Full Text] [Related]
16. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321 [TBL] [Abstract][Full Text] [Related]
17. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Kulasingam V; Diamandis EP Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711 [TBL] [Abstract][Full Text] [Related]
18. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. Zheng X; Baker H; Hancock WS J Chromatogr A; 2006 Jul; 1120(1-2):173-84. PubMed ID: 16527286 [TBL] [Abstract][Full Text] [Related]
20. Data analysis of assorted serum peptidome profiles. Villanueva J; Philip J; DeNoyer L; Tempst P Nat Protoc; 2007; 2(3):588-602. PubMed ID: 17406620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]